Compare VMC & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VMC | WAT |
|---|---|---|
| Founded | 1909 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.2B | 33.5B |
| IPO Year | 2007 | 1996 |
| Metric | VMC | WAT |
|---|---|---|
| Price | $300.89 | $360.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 17 |
| Target Price | $323.17 | ★ $379.19 |
| AVG Volume (30 Days) | ★ 1.2M | 812.3K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | ★ 18.39 | 0.47 |
| EPS | ★ 1.26 | N/A |
| Revenue | ★ $7,781,900,000.00 | N/A |
| Revenue This Year | $1.85 | $104.66 |
| Revenue Next Year | $6.22 | $10.40 |
| P/E Ratio | $232.53 | ★ N/A |
| Revenue Growth | ★ 6.38 | N/A |
| 52 Week Low | $252.35 | $275.05 |
| 52 Week High | $331.09 | $414.15 |
| Indicator | VMC | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 64.75 | 56.10 |
| Support Level | $292.44 | $285.73 |
| Resistance Level | $313.36 | $392.00 |
| Average True Range (ATR) | 8.17 | 12.61 |
| MACD | 2.71 | -2.21 |
| Stochastic Oscillator | 95.68 | 42.75 |
Vulcan Materials is the United States' largest producer of construction aggregates (crushed stone, sand, and gravel). Its largest markets include Texas, California, Virginia, Tennessee, Georgia, Florida, North Carolina, and Alabama. In 2024, Vulcan sold 219.9 million tons of aggregates, 13.6 million tons of asphalt mix, and 3.6 million cubic yards of ready-mix. As of Dec. 31, 2024, the company had 16.5 billion tons of aggregate reserves.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.